Eficacia de la lidocaína al 2% y la articaína al 4% en molares mandibulares con diferentes diagnósticos pulpares en la técnica mandibular 
INTRODUCTION
The mandibular technique is the block method most frequently used in anesthetizing mandibular molars during endodontic treatments. However, the failures reported after the use of this technique range from 10% to 81%, with higher values in teeth with inflamed dental pulp. 1, 2 Several studies have compared lidocaine and articaine in mandibular techniques, with some showing no statistically significant differences between these anesthetic solutions, in contrast to other trials that suggest that articaine is superior in terms of the degree of pulp anesthesia when compared with lidocaine. [3] [4] [5] In 2017, Aggarwal et al 6 conducted a clinical trial to evaluate the efficacy of 2% lidocaine with 1:200,000 epinephrine, 4% articaine with 1:100,000 epinephrine, and 0.5% bupivacaine with 1:200,000 epinephrine in mandibular block in patients with asymptomatic irreversible pulpitis, finding out clinical differences between articaine and the other studied solutions, but with no statistical significance.
In 2012, Kanna et al, 7 in a study in 182 patients with irreversible pulpitis in mandibular teeth, concluded that conventional mandibular block using 2% lidocaine with 1:80,000 epinephrine does not provide a painfree endodontic procedure, and that complementary vestibular infiltration using 4% articaine with 1:100,000 epinephrine and intraosseous anaesthesia using 2% lidocaine with epinephrine provides a painless procedure with successful pulpal anaesthesia averaging 84% and 68%, respectively.
This study aimed to compare the anesthetic efficacy of 2% lidocaine with 1:80,000 epinephrine and 4% articaine with 1:100,000 epinephrine in lower molars with vital pulp in a mandibular block, and to analyze the relationship between anesthetic efficacy and diagnosis.
MATERIALS AND METHODS
This was a randomized, double-blind, parallelcontrolled clinical trial, not listed in Clinical Trials. It was registered with the Department of Research of the School of Dentistry and was not evaluated by the Ethics Committee of Universidad de Cartagena. All patients signed a written informed consent to participate. The sample included 36 subjects over 18 years of age requiring endodontic treatment in a mandibular molar with vital pulp. The researchers first standardized the criteria for pulp diagnosis, obtaining a Kappa index of 0.80. The researcher with the highest index value was calibrated, taking into account the 2009 criteria of the American Endodontic Association. 8 The clinical history of each patient was recorded, excluding those with a history of allergies to lidocaine or articaine, as well as patients in pregnancy, with contraindications to the use of epinephrine, and those using consciousness-altering medications. Sample size was calculated using the EPINFO TM software (Centers for Disease Control and Prevention, USA) and its StatCalc application. The statistical formula was used to compare two independent means, and the calculation yielded 15 subjects for each group. Considering a dropout of 10%, each group was increased to 18 patients, for a total of 36 participants.
Two local anesthetics were used: 2% lidocaine with 1:80,000 epinephrine (Roxicaína ® 2%-E80, Ropsohn Therapeutics, Colombia) and 4% articaine with 1:100,000 epinephrine (Artheek ® 4%-E100; Newstetic, Colombia). The anesthetic cartridges were masked by a third person who did not belong to the research team, who removed the label of the active ingredient and used colors to encode each cartridge according to the active ingredient. The cartridges were inserted in encoded envelopes, one for each group. Data analysis was done using this codification and the blinding was removed at the end of the clinical trial. In addition, the anesthetic solution that was applied to each patient was dosed, as each cartridge was externally divided into four equal parts and marked with a non-erasable marker, to ensure that each patient was applied the same amount of anesthetic solution as follows: 2 / 4 of the cartridge were applied in the inferior dental nerve, ¼ in the lingual nerve and ¼ in the long buccal nerve.
The researchers were unaware of the solution with which each patient was anesthetized. The 36 subjects were randomly allocated to two groups using block randomization. Each subject's allocation was hidden using opaque and sealed envelopes that were delivered at the study site where the procedure was carried out on the day of each patient's consultation. An assistant was in charge of keeping the anesthetics in sealed envelopes according to the allocations. All patients received 1.8 ml of 2% lidocaine with 1:80,000 epinephrine or 4% articaine with 1:100,000 epinephrine in a unilateral mandibular technique, with anesthesia of the buccal length in a second phase in the molar region, after blood suction. All anesthetic injections were applied by the same operator, who also assessed the results and performed the clinical procedures. Soft tissue anesthesia was tested 3 minutes afterwards using the tip of a probe on the skin of the lip, the vestibular mucosa, and the tip of the tongue of the anesthetized side.
Pulp sensitivity was determined using a vitalometer (Analytic Technology, Redmond, WA, USA). The contralateral molar was evaluated with the vitalometer, in order to validate its reading and for the patient to perceive how the stimulus felt in the absence of anesthesia. This evaluation was performed 10 minutes before starting the test. In all cases, the electric pulp testing was done in the vestibular side of the mandibular molar to be treated in the anesthetized side, 5 and 10 minutes after injecting the anesthetic, to verify the degree of pulp anesthesia and to determine success according to the criteria of the clinical trial (two consecutive readings at a maximum stimulation of 80). The two vitalometer readings were followed by pulp chamber opening, recording any expression of pain by the patient during this phase; in this case, pain was measured by visual analogue scale (VAS) depending on how the subject classified this pain, considering the following ranges: 0-3: absent to mild, 4-6: moderate, 7-10: very intense. In case the pain referred by the patient was in the range of 4 to 10 (moderate to intense), an intraligamental technique was carried out in the treated molar, followed by pulp chamber access, assessing the presence of pain when using the intraligamental technique. If the patient referred moderate to severe pain (VAS), an intrapulpal technique was used. The researchers collected information on the use of one or both complementary techniques in each treated subject. 17 patients (47.2%) were diagnosed with asymptomatic irreversible pulpitis. 55.6% of these (n = 10) were anesthetized with lidocaine and 38.9% (n = 7) with articaine. 30.6% of patients (n = 11) had normal pulp, and of these, 27.8% were anesthetized with lidocaine and 33.3% with articaine (Table 1) . The frequency of successful pulpal anesthesia, determined by the vitalometer (two consecutive readings of 80), was 13.9%, being 5.6% (n = 1) for the lidocaine group and 22.2% (n = 4) for the articaine group. No statistically significant differences (p = 0.33) were observed between the anesthetic solutions assessed and the frequency of successful pulpal anesthesia determined by vitalometry (Table 3) . Of the 5 patients (13.9%) in whom successful pulpal anesthesia was achieved, 27.3% (n = 3) had normal pulp, while successful pulpal anesthesia in teeth with asymptomatic and symptomatic irreversible pulpitis was achieved in 5.8% and 12.5% respectively (Table 4 ). 61.1% of patients (n = 22) reported pain during the opening of the pulp chamber, with an equal distribu tion in both groups (n = 11; 61.1%). Table 6 shows that there were no statistically significant differences in pain incidence when administering lidocaine and articaine (p = 0.633). Pain during the opening of the chamber was evaluated through visual analogue scale (VAS). 19 patients (86.4%) considered it as severe pain-7 to 10 in VAS (mean ± SD: 4.9 ± 4.2, p = 0.633). 100% of the patients in the lidocaine group considered the pain during the opening as severe (mean ± SD: 5.2 ± 4.4), while 72.7% (n = 8) of the articaine group classified it at this level (mean ± SD: 4.7 ± 4.1). No patient considered the opening of the pulp chamber as mild pain. The data showed no statistically significant differences between the groups (p = 0.728). Of the 22 patients who needed complementary techniques, 30.6% (n = 11) required the application of two techniques (intraligamental and intrapulpal), 6 patients (33.3%) of the lidocaine group and 5 patients (27.8%) of the articaine group. The most used complementary technique was the intraligamental (27.8%; n = 10).
E p u b a h e a d o f p r i n t

DISCUSSION
Several studies have compared the efficacy of 4% articaine with epinephrine and 2% lidocaine with epinephrine in mandibular or alveolar inferior dental nerve blocks, but the results have not been consistent. 3, 9 4% articaine has proven to be more effective in achieving successful pulp anesthesia in molars after buccal infiltration; 4, 5 on the other hand, no statistically significant differences in anesthetic efficacy have been reported when comparing these two anesthetics in mandibular blocks. A clinical trial in 91 patients, published by Aggarwal et al 6 in 2017, showed that by comparing these two anesthetic solutions and 0.5% bupivacaine with epinephrine 1:200,000 in a mandibular block in patients with asymptomatic irreversible pulpitis (evaluating the anesthetic success by the absence of pain during the opening of the pulp chamber with VAS), 4% articaine was more effective (33%) than the other solutions assessed, but with no statistically significant differences.
Sood et al 9 reported that 4% articaine with 1:100,000 epinephrine was more effective in providing successful pulp anesthesia (76%) than 2% lidocaine 1:80,000 (58%) in a mandibular block in teeth with irreversible pulpitis, like in the present study, in which the data demonstrate a better effect of articaine in terms of pulp anesthesia, with values of 22.2% for articaine and 5.6% for lidocaine respectively. In evaluating pain during the opening of the pulp chamber, Sood et al 9 reported that the articaine group showed a slight increase in pain (88%) compared to the lidocaine group (82%), differing from the findings of the present study, in which both groups referred pain to pulp chamber opening in the same proportion (61%).
In 2016, Fowler et al 10 published a retrospective study to determine the anesthetic efficacy of mandibular block using 2% lidocaine with 1:100,000 epinephrine and supplementary vestibular infiltration with 4% articaine in patients with acute irreversible pulpitis. The authors reported successful pulp anesthesia in 28% of first molars and 25% of second molars during mandibular block with lidocaine. When performing an oral infiltration with articaine, the anesthetic success improved by 42% in the first molar and by 48% in the second, with no statistically significant findings. In our study, pulp anesthesia with 2% lidocaine (5.6%) and 4% articaine (22.2%) was lower than the values reported by Fowler et al, 10 considering that both solutions were used in the primary technique in each group without infiltrating with articaine in vestibular.
Yadav et al 4 conducted a clinical trial in 115 patients who had molars with irreversible pulpitis, evaluating the anesthetic success by the absence or presence of moderate pain during the opening of the chamber. The authors reported that 2% lidocaine with epinephrine 1:80,000 showed a success rate of 32%, while the success rate of 4% articaine with epinephrine 1:100,000 and buccal infiltration was 76%. These rates increased significantly in the group premedicated with ketorolac and oral infiltration with articaine (76%). The results of the present study are similar in terms of lidocaine (38.9%), but The superiority of 4% articaine over 2% lidocaine in mandibular block in patients with vital pulp could not be statistically verified in the present study. Both solutions presented similar behavior, although 4% articaine showed better pulpal anesthetic success rate (22.2%).
Successful pulp anesthesia is reduced in patients with asymptomatic irreversible pulpitis (5.8%), compared with normal pulp (27.3%). This can be explained by factors present in the inflamed pulp tissue, like an acid pH and the presence of inflammation mediators, which produce allodynia and hyperalgesia, contributing to a poor efficacy of anesthesia in patients with diagnoses of pulpitis. 11 The findings of the present study show that successful pulp anesthesia in mandibular molars is low (13.9%), regardless of the anesthetic solution used. This study showed that there are no statistically significant differences between the two solutions when used in a mandibular technique to control pain during the opening of the pulp chamber and that the use of complementary techniques was needed to complete the endodontic treatment.
The use of 2% lidocaine and 4% articaine has proven to be safe in terms of toxicity and associated complications, [12] [13] [14] [15] with very low incidence of paresthesia, allergic reactions, and other complications related to the use of local anesthetics. [16] [17] [18] From the clinical perspective, the results of this report question the efficacy of pulp anesthesia after using a conventional mandibular technique. [18] [19] [20] [21] The use of 4% articaine improved pulpal anesthesia in mandibular molars; however, it is still a very weak pulp anesthesia. The challenge dentists face today is to achieve successful pulp anesthesia in mandibular molars with diagnoses of pulp inflammation. In this regard, other studies show promising results when using articaine with buccal infiltration following inferior dental nerve block.
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